losartan has been researched along with Hypotension in 38 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Hypotension: Abnormally low BLOOD PRESSURE that can result in inadequate blood flow to the brain and other vital organs. Common symptom is DIZZINESS but greater negative impacts on the body occur when there is prolonged depravation of oxygen and nutrients.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the first dose responses to low dose captopril and losartan in patients with acute myocardial infarction." | 9.09 | First dose hypotension after angiotensin converting enzyme inhibitor captopril and angiotensin II blocker losartan in patients with acute myocardial infarction. ( Fischerova, B; Pluhacek, L; Spinar, J; Spinarova, L; Toman, J; Vitovec, J, 2000) |
| " We hypothesised that anaesthesia-induced hypotension causes renal vasoconstriction and decreased oxygen delivery via angiotensin II-mediated renal vasoconstriction." | 7.96 | Pre-treatment with the angiotensin receptor 1 blocker losartan protects renal blood flow and oxygen delivery after propofol-induced hypotension in pigs. ( Franzén, S; Frithiof, R, 2020) |
| "The authors aimed to test the hypothesis that xenon anesthesia limits adverse hypotensive effects of losartan during acute hemorrhage." | 7.76 | Xenon/remifentanil anesthesia protects against adverse effects of losartan on hemodynamic challenges induced by anesthesia and acute blood loss. ( Boemke, W; Francis, RC; Klein, A; Philippi-Höhne, C; Pickerodt, PA; Reyle-Hahn, MS, 2010) |
| " This report describes a case of acute compromise of renal function associated with hypotension in a 7-year-old boy treated with the ACE inhibitor lisinopril and the ARB losartan." | 7.73 | Acute renal failure during lisinopril and losartan therapy for proteinuria. ( Hanevold, CD, 2006) |
| "The effects of the angiotensin II (ANG II) AT2 ligand PD 123319 and the AT1 antagonist losartan on cerebral blood flow (CBF) were studied during hemorrhagic hypotension in anesthetized rats using laser-Doppler flowmetry." | 7.69 | Angiotensin II AT2 receptor stimulation increases cerebrovascular resistance during hemorrhagic hypotension in rats. ( Näveri, L; Saavedra, JM; Strömberg, C, 1994) |
| "Inhibitors of angiotensin converting enzyme, renin, and the angiotensin II (Ang II) receptor lower the blood pressure of spontaneously hypertensive rats (SHR) used as a model of essential hypertension." | 7.68 | Roles of renal and vascular renin in spontaneous hypertension and switching of the mechanism upon nephrectomy. Lack of hypotensive effects of inhibition of renin, converting enzyme, and angiotensin II receptor blocker after bilateral nephrectomy. ( Higuchi, K; Inagami, T; Murakami, T; Nakajo, S, 1991) |
| "In this IPD meta-analysis of hospitalized COVID-19 patients, we found no convincing evidence for the benefit of losartan versus control treatment, but a higher rate of hypotension adverse events with losartan." | 5.41 | Losartan in hospitalized patients with COVID-19 in North America: An individual participant data meta-analysis. ( Baksh, SN; Bengtson, CD; Bierer, BE; Di Stefano, L; Freilich, DA; Gadomski, A; Geriak, M; Hanley, DF; Khanal, P; Li, T; McBee, N; Puskarich, MA; Ram, M; Salathe, MA; Scharfstein, DO; Schutte, AE; Tignanelli, CJ; Victory, J, 2023) |
| "To compare the first dose responses to low dose captopril and losartan in patients with acute myocardial infarction." | 5.09 | First dose hypotension after angiotensin converting enzyme inhibitor captopril and angiotensin II blocker losartan in patients with acute myocardial infarction. ( Fischerova, B; Pluhacek, L; Spinar, J; Spinarova, L; Toman, J; Vitovec, J, 2000) |
| " We hypothesised that anaesthesia-induced hypotension causes renal vasoconstriction and decreased oxygen delivery via angiotensin II-mediated renal vasoconstriction." | 3.96 | Pre-treatment with the angiotensin receptor 1 blocker losartan protects renal blood flow and oxygen delivery after propofol-induced hypotension in pigs. ( Franzén, S; Frithiof, R, 2020) |
| "The authors aimed to test the hypothesis that xenon anesthesia limits adverse hypotensive effects of losartan during acute hemorrhage." | 3.76 | Xenon/remifentanil anesthesia protects against adverse effects of losartan on hemodynamic challenges induced by anesthesia and acute blood loss. ( Boemke, W; Francis, RC; Klein, A; Philippi-Höhne, C; Pickerodt, PA; Reyle-Hahn, MS, 2010) |
| " In the present study, we tested the hypothesis that the OVLT mediates the hypertension or the hypotension produced by chronic infusion of ANG II or losartan (AT1 antagonist), respectively." | 3.76 | Role of the organum vasculosum of the lamina terminalis for the chronic cardiovascular effects produced by endogenous and exogenous ANG II in conscious rats. ( Collister, JP; Nahey, DB; Vieira, AA, 2010) |
| " (3) Five clinical trials have evaluated angiotensin II receptor antagonists (candesartan, losartan and valsartan) in terms of their effect on mortality and on the risk of clinical deterioration in patients with symptomatic heart failure, but without severe renal failure, hyperkalemia or hypotension." | 3.73 | Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option. ( , 2005) |
| " This report describes a case of acute compromise of renal function associated with hypotension in a 7-year-old boy treated with the ACE inhibitor lisinopril and the ARB losartan." | 3.73 | Acute renal failure during lisinopril and losartan therapy for proteinuria. ( Hanevold, CD, 2006) |
| "Arterial hypertension significantly decreased after the introduction of losartan (p = 0." | 3.72 | Renoprotective effects of losartan in renal transplant recipients. Results of a retrospective study. ( Anaya, F; Campistol, JM; Del Castillo, D; Esforzado, N; Iñigo, P; Navarro, MD; Oppenheimer, F; Saracho, R, 2003) |
| "We have investigated the role of peripheral angiotensin II in the generation of hypotension (without hypovolaemia)-induced salt intake in rats treated with an IV infusion of the quaternary ammonium peripheral ganglion blocker Penthonium." | 3.69 | An angiotensin-independent, hypotension-induced, sodium appetite in the rat. ( Nicolaïdis, S; Sanchez, A; Thornton, SN, 1995) |
| "The selective angiotensin (ANG) II antagonists losartan (AT1) and CGP-42112A (AT2) were used to determine the receptor subtype and neuronal pathways that mediate the hypotension and bradycardia produced by 200 fmol of ANG II microinjected into the dorsal medial nucleus tractus solitarii (NTS) or dorsal motor nucleus of the vagus (dmnX) in anesthetized rats." | 3.69 | Mechanisms of angiotensin-induced hypotension and bradycardia in the medial solitary tract nucleus. ( Averill, DB; Barnes, KL; Fow, JE, 1994) |
| "The effects of the angiotensin II (ANG II) AT2 ligand PD 123319 and the AT1 antagonist losartan on cerebral blood flow (CBF) were studied during hemorrhagic hypotension in anesthetized rats using laser-Doppler flowmetry." | 3.69 | Angiotensin II AT2 receptor stimulation increases cerebrovascular resistance during hemorrhagic hypotension in rats. ( Näveri, L; Saavedra, JM; Strömberg, C, 1994) |
| "Inhibitors of angiotensin converting enzyme, renin, and the angiotensin II (Ang II) receptor lower the blood pressure of spontaneously hypertensive rats (SHR) used as a model of essential hypertension." | 3.68 | Roles of renal and vascular renin in spontaneous hypertension and switching of the mechanism upon nephrectomy. Lack of hypotensive effects of inhibition of renin, converting enzyme, and angiotensin II receptor blocker after bilateral nephrectomy. ( Higuchi, K; Inagami, T; Murakami, T; Nakajo, S, 1991) |
| " Third-standard-dose triple antihypertensive combination therapy demonstrated early effective BP control compared to third-standard-dose dual combination therapies, without increasing adverse drug reactions in patients with mild-to-moderate hypertension." | 3.30 | Comparison of efficacy and safety between third-dose triple and third-dose dual antihypertensive combination therapies in patients with hypertension. ( Cho, DK; Cho, GY; Cho, JM; Heo, JH; Hong, SJ; Jeong, MH; Jung, JA; Kim, DH; Kim, SH; Kim, SY; Kim, W; Kwon, K; Lee, HY; Lee, JB; Lim, SW; Park, K; Park, S; Pyun, WB; Rha, SW; Rhee, MY; Shin, J; Sung, KC, 2023) |
| " Downward dosage adjustment appeared essential and may have prevented hypotension-related pathology." | 1.42 | Summertime dosage-dependent hypersensitivity to an angiotensin II receptor blocker. ( Forsdyke, DR, 2015) |
| " Chronic administration of Rut (10, 20, or 40 mg/kg/day, respectively) for 4 weeks caused a depressor effect and significantly regressed the lumen diameter and decreased the medium thickness of mesenteric arteries in hypertensive rats concomitantly with an increase in the plasma concentration of CGRP and the expression of CGRP mRNA in DRG." | 1.34 | Calcitonin gene-related Peptide-mediated depressor effect and inhibiting vascular hypertrophy of rutaecarpine in renovascular hypertensive rats. ( Chen, QQ; Deng, HW; Hu, GY; Li, D; Li, YJ; Luo, D; Qin, XP; Zeng, SY; Zhang, Z, 2007) |
| " To test this hypothesis, we have used a novel approach to effectively "clamp" the sympathetic nervous system at a fixed level through chronic administration of the ganglionic blocking agent hexamethonium (15 mg/kg/h) and the alpha agonist phenylephrine (2." | 1.33 | Role of a responsive sympathetic nervous system in the chronic hypotensive effects of losartan in normal rats. ( Collister, JP; Osborn, JW, 2005) |
| " Dose-response curves to bradykinin (0." | 1.31 | Acute administration of nicotine impairs the hypotensive responses to bradykinin in rats. ( Calegari, V; do Prado, JF; Moreno, H; Paganelli, MO; Tanus-Santos, JE; Toledo, JC, 2001) |
| "Losartan was thus safely used for this patient during treatment by LDL apheresis." | 1.31 | Effects of losartan on blood pressure and humoral factors in a patient who suffered from anaphylactoid reactions when treated with ACE inhibitors during LDL apheresis. ( Inami, S; Kojima, S; Kuramochi, M; Shida, M; Takano, H; Yodogawa, K; Yokoyama, H, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (23.68) | 18.2507 |
| 2000's | 17 (44.74) | 29.6817 |
| 2010's | 7 (18.42) | 24.3611 |
| 2020's | 5 (13.16) | 2.80 |
| Authors | Studies |
|---|---|
| Sung, KC | 1 |
| Hong, SJ | 1 |
| Rhee, MY | 1 |
| Jeong, MH | 1 |
| Kim, DH | 1 |
| Lim, SW | 1 |
| Park, K | 1 |
| Lee, JB | 1 |
| Kim, SY | 1 |
| Cho, JM | 1 |
| Cho, GY | 1 |
| Heo, JH | 1 |
| Kim, SH | 1 |
| Lee, HY | 1 |
| Kim, W | 1 |
| Cho, DK | 1 |
| Park, S | 1 |
| Shin, J | 1 |
| Pyun, WB | 1 |
| Kwon, K | 1 |
| Rha, SW | 1 |
| Jung, JA | 1 |
| Di Stefano, L | 1 |
| Ram, M | 1 |
| Scharfstein, DO | 1 |
| Li, T | 1 |
| Khanal, P | 1 |
| Baksh, SN | 1 |
| McBee, N | 1 |
| Bengtson, CD | 1 |
| Gadomski, A | 1 |
| Geriak, M | 1 |
| Puskarich, MA | 1 |
| Salathe, MA | 1 |
| Schutte, AE | 1 |
| Tignanelli, CJ | 1 |
| Victory, J | 1 |
| Bierer, BE | 1 |
| Hanley, DF | 1 |
| Freilich, DA | 1 |
| Franzén, S | 2 |
| Frithiof, R | 2 |
| Drobek, HH | 1 |
| Porwolik, M | 1 |
| Pietrauszka, K | 1 |
| Miziołek, B | 1 |
| Bergler-Czop, B | 1 |
| Brzezińska-Wcisło, L | 1 |
| Näslund, E | 1 |
| Wang, H | 1 |
| Morgan, D | 1 |
| Rasmussen, MG | 1 |
| Barklin, A | 1 |
| Han, S | 1 |
| Jeong, AL | 1 |
| Lee, S | 1 |
| Park, JS | 1 |
| Buyanravjikh, S | 1 |
| Kang, W | 1 |
| Choi, S | 1 |
| Park, C | 1 |
| Han, J | 1 |
| Son, WC | 1 |
| Yoo, KH | 1 |
| Cheong, JH | 1 |
| Oh, GT | 1 |
| Lee, WY | 1 |
| Kim, J | 1 |
| Suh, SH | 1 |
| Lee, SH | 1 |
| Lim, JS | 1 |
| Lee, MS | 1 |
| Yang, Y | 1 |
| Forsdyke, DR | 1 |
| Brunette-Lawrey, E | 1 |
| Croft, F | 1 |
| Collister, JP | 7 |
| Nahey, DB | 2 |
| Ployngam, T | 1 |
| Katz, SS | 1 |
| Francis, RC | 1 |
| Philippi-Höhne, C | 1 |
| Klein, A | 1 |
| Pickerodt, PA | 1 |
| Reyle-Hahn, MS | 1 |
| Boemke, W | 1 |
| Vieira, AA | 1 |
| Luippold, G | 1 |
| Max, A | 1 |
| Albinus, M | 1 |
| Osswald, H | 1 |
| Mühlbauer, B | 1 |
| Hendel, MD | 2 |
| Iñigo, P | 1 |
| Campistol, JM | 1 |
| Saracho, R | 1 |
| Del Castillo, D | 1 |
| Anaya, F | 1 |
| Esforzado, N | 1 |
| Navarro, MD | 1 |
| Oppenheimer, F | 1 |
| Kinugawa, S | 1 |
| Post, H | 1 |
| Kaminski, PM | 1 |
| Zhang, X | 1 |
| Xu, X | 1 |
| Huang, H | 1 |
| Recchia, FA | 1 |
| Ochoa, M | 1 |
| Wolin, MS | 1 |
| Kaley, G | 1 |
| Hintze, TH | 1 |
| Osborn, JW | 2 |
| Hanevold, CD | 1 |
| Qin, XP | 1 |
| Zeng, SY | 1 |
| Li, D | 1 |
| Chen, QQ | 1 |
| Luo, D | 1 |
| Zhang, Z | 1 |
| Hu, GY | 1 |
| Deng, HW | 1 |
| Li, YJ | 1 |
| Thornton, SN | 1 |
| Sanchez, A | 1 |
| Nicolaïdis, S | 1 |
| Fow, JE | 1 |
| Averill, DB | 1 |
| Barnes, KL | 1 |
| Näveri, L | 1 |
| Strömberg, C | 1 |
| Saavedra, JM | 1 |
| Hornfeldt, BJ | 1 |
| Rowland, NE | 1 |
| Fregly, MJ | 1 |
| Rozelle, AK | 1 |
| Morien, A | 1 |
| Pintus, S | 1 |
| Pintus, P | 1 |
| Maxia, P | 1 |
| Anedda, S | 1 |
| Whorlow, SL | 1 |
| Angus, JA | 1 |
| Wright, CE | 1 |
| Nowicki, PT | 1 |
| Minnich, LA | 1 |
| Matys, T | 1 |
| Pawlak, R | 1 |
| Kucharewicz, I | 1 |
| Chabielska, E | 1 |
| Buczko, W | 1 |
| Tanus-Santos, JE | 2 |
| Gordo, WM | 1 |
| Francisco-DoPrado, J | 1 |
| Sampaio, RC | 1 |
| Moreno, H | 2 |
| Sosa-Canache, B | 1 |
| Cierco, M | 1 |
| Gutierrez, CI | 1 |
| Israel, A | 1 |
| Spinar, J | 1 |
| Vitovec, J | 1 |
| Pluhacek, L | 1 |
| Spinarova, L | 1 |
| Fischerova, B | 1 |
| Toman, J | 1 |
| Paganelli, MO | 1 |
| Toledo, JC | 1 |
| do Prado, JF | 1 |
| Calegari, V | 1 |
| Kojima, S | 1 |
| Shida, M | 1 |
| Takano, H | 1 |
| Inami, S | 1 |
| Yodogawa, K | 1 |
| Yokoyama, H | 1 |
| Kuramochi, M | 1 |
| Carey, RM | 1 |
| Howell, NL | 1 |
| Jin, XH | 1 |
| Siragy, HM | 1 |
| Inagami, T | 1 |
| Murakami, T | 1 |
| Higuchi, K | 1 |
| Nakajo, S | 1 |
3 reviews available for losartan and Hypotension
| Article | Year |
|---|---|
Losartan in hospitalized patients with COVID-19 in North America: An individual participant data meta-analysis.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Bayes Theorem; COVID-19; | 2023 |
What is the Best Way to Treat Patients with Raynaud's Phenomenon and a Tendency towards Hypotension?
Topics: Antihypertensive Agents; Calcium Channel Blockers; Humans; Hypotension; Losartan; Nifedipine; Nitrog | 2020 |
Relationship between the drinking response to angiotensin II and induction of Fos in the brain.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Brain; Catheterizatio | 1996 |
2 trials available for losartan and Hypotension
| Article | Year |
|---|---|
Comparison of efficacy and safety between third-dose triple and third-dose dual antihypertensive combination therapies in patients with hypertension.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Chlorthalidone; Double-Blind Method; Drug Thera | 2023 |
First dose hypotension after angiotensin converting enzyme inhibitor captopril and angiotensin II blocker losartan in patients with acute myocardial infarction.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; | 2000 |
33 other studies available for losartan and Hypotension
| Article | Year |
|---|---|
Pre-treatment with the angiotensin receptor 1 blocker losartan protects renal blood flow and oxygen delivery after propofol-induced hypotension in pigs.
Topics: Anesthetics, Intravenous; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Female; Hypoten | 2020 |
Prevention of hemorrhage-induced renal vasoconstriction and hypoxia by angiotensin II type 1 receptor antagonism in pigs.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Disease Models, Animal; Hemodynamics; Hemorrhage; | 2021 |
[Methylene blue against refractory hypotension].
Topics: Angiotensin II Type 1 Receptor Blockers; Enzyme Inhibitors; Humans; Hypotension; Losartan; Male; Met | 2017 |
C1q/TNF-α-Related Protein 1 (CTRP1) Maintains Blood Pressure Under Dehydration Conditions.
Topics: Adipokines; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Cell Line; Cells, Cult | 2018 |
Summertime dosage-dependent hypersensitivity to an angiotensin II receptor blocker.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Dose-Response Rela | 2015 |
Losartan and amlodipine overdose-Case Report of a patient with anuric renal failure prior to the onset of hypotension.
Topics: Acute Kidney Injury; Amlodipine; Antihypertensive Agents; Anuria; Drug Overdose; Female; Humans; Hyp | 2016 |
The cardiovascular response of normal rats to dual lesion of the subfornical organ and area postrema at rest and to chronic losartan.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensins; Animals; Area Postrema; Blood Pressure; Cardi | 2009 |
Role of the median preoptic nucleus in the chronic hypotensive effect of losartan in sodium-replete normal rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cardiac Output; Heart Rate; Hypotension; Ibotenic | 2010 |
Xenon/remifentanil anesthesia protects against adverse effects of losartan on hemodynamic challenges induced by anesthesia and acute blood loss.
Topics: Anesthesia; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Dogs; Female; Hemodynamics; H | 2010 |
Role of the organum vasculosum of the lamina terminalis for the chronic cardiovascular effects produced by endogenous and exogenous ANG II in conscious rats.
Topics: Analysis of Variance; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressu | 2010 |
Role of the renin-angiotensin system in the compensation of quinpirole-induced blood pressure decrease.
Topics: Anesthesia; Angiotensin II; Animals; Blood Pressure; Denervation; Dose-Response Relationship, Drug; | 2003 |
The role of Ang (1-7) in mediating the chronic hypotensive effects of losartan in normal rats.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Chronic Disease; Dr | 2003 |
Renoprotective effects of losartan in renal transplant recipients. Results of a retrospective study.
Topics: Anemia; Antihypertensive Agents; Cough; Creatinine; Female; Follow-Up Studies; Humans; Hyperkalemia; | 2003 |
Coronary microvascular endothelial stunning after acute pressure overload in the conscious dog is caused by oxidant processes: the role of angiotensin II type 1 receptor and NAD(P)H oxidase.
Topics: Acetophenones; Angiotensin II; Animals; Ascorbic Acid; Bradycardia; Bradykinin; Coronary Circulation | 2003 |
Subfornical organ lesion attenuates chronic hypotensive effects of losartan in salt-replete rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Body Wate | 2003 |
Role of a responsive sympathetic nervous system in the chronic hypotensive effects of losartan in normal rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Chronic Disease; Ganglionic Blocke | 2005 |
Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; C | 2005 |
Acute renal failure during lisinopril and losartan therapy for proteinuria.
Topics: Acute Kidney Injury; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibito | 2006 |
Calcitonin gene-related Peptide-mediated depressor effect and inhibiting vascular hypertrophy of rutaecarpine in renovascular hypertensive rats.
Topics: Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Vessels; Calcitonin Ge | 2007 |
An angiotensin-independent, hypotension-induced, sodium appetite in the rat.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Appetite; Biphenyl Compounds; Bis-Trimeth | 1995 |
Mechanisms of angiotensin-induced hypotension and bradycardia in the medial solitary tract nucleus.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Bradycardia; Cardiova | 1994 |
Angiotensin II AT2 receptor stimulation increases cerebrovascular resistance during hemorrhagic hypotension in rats.
Topics: Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; | 1994 |
Hypotensive response to losartan in normal rats. Role of Ang II and the area postrema.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Cerebral Ventr | 1996 |
Use of losartan in FH patients during treatment with DSC-LDL apheresis.
Topics: Angiotensin II; Blood Component Removal; Dextran Sulfate; Humans; Hyperlipoproteinemia Type II; Hypo | 1997 |
Endogenous angiotensin II and bradykinin delay and attenuate the hypotension after N-type calcium channel blockade in conscious rabbits.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti | 1998 |
Effects of systemic hypotension on postnatal intestinal circulation: role of angiotensin.
Topics: Aging; Angiotensin II; Animals; Animals, Newborn; Hemodynamics; Hypotension; In Vitro Techniques; In | 1999 |
Hypotensive effect of angiotensin II after AT1-receptor blockade with losartan.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; | 2000 |
Endothelin-1 attenuates bradykinin-induced hypotension in rats.
Topics: Administration, Oral; Animals; Blood Pressure; Bradykinin; Dose-Response Relationship, Drug; Enalapr | 2000 |
Role of bradykinins and nitric oxide in the AT2 receptor-mediated hypotension.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blo | 2000 |
Acute administration of nicotine impairs the hypotensive responses to bradykinin in rats.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensiv | 2001 |
Effects of losartan on blood pressure and humoral factors in a patient who suffered from anaphylactoid reactions when treated with ACE inhibitors during LDL apheresis.
Topics: Aldosterone; Anaphylaxis; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting E | 2001 |
Angiotensin type 2 receptor-mediated hypotension in angiotensin type-1 receptor-blocked rats.
Topics: Angiotensin Receptor Antagonists; Animals; Blood Pressure Determination; Diet, Sodium-Restricted; Hy | 2001 |
Roles of renal and vascular renin in spontaneous hypertension and switching of the mechanism upon nephrectomy. Lack of hypotensive effects of inhibition of renin, converting enzyme, and angiotensin II receptor blocker after bilateral nephrectomy.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; | 1991 |